Category: medicine

Haile added that the anti-fentanyl antibodies didn’t cross-react with other opioids, meaning a vaccinated person could still be treated for pain relief with other opioids. The vaccine did not cause any adverse side effects in rats involved in lab studies, and clinical trials in humans are planned “soon,” with manufacturing of clinical-grade vaccine to begin in the coming months.

Psilocybin, the active hallucinogen found in psychedelic mushrooms — also known as “magic mushrooms” — can effectively alleviate a severe bout of depression when administered in a single dose and combined with talk therapy, a new clinical study found.

Adults with depression who were administered a single 25-miligram dose of psilocybin were more likely to experience significant improvements in their mental health — both immediately and for up to three months — than others who were randomly assigned smaller doses of the same drug, said the peer-reviewed study, which was published Wednesday in the New England Journal of Medicine….

The trial’s findings could be an encouraging sign for the 16 million Americans estimated each year by the Centers for Disease Control and Prevention to have depression, many of whom struggle to find treatments that work for them. Its authors hope the study — which was relatively small, with just 79 participants receiving the 25 mg dose — will pave the way for eventual regulatory approval of psilocybin by the Food and Drug Administration for use as a drug against depression….

Notwithstanding the headaches, nausea and dizziness reported by many as adverse side effects, most of the adults enjoyed the experience.
The Post got an interesting reponse from James Rucker, a consultant psychiatrist at King’s College London who worked on the trial. He said there’s something about the psychedelic experience that leads to a rapid resolution of depression symptoms, adding “We don’t really know what that is at the moment, but it’s very different to standard antidepressants….”

“What people forget about psychedelics is that they were being used as medicines prior to 1971 when they essentially got caught up in the drugs war,” Rucker added. “We’re just picking up the baton of history.”

Thanks to Slashdot reader Shmoodling for submitting the story.

In 2014 they’d spotted the same photo “being used in two different papers to represent results from three entirely different experiments….”

Although this was eight years ago, I distinctly recall how angry it made me. This was cheating, pure and simple. By editing an image to produce a desired result, a scientist can manufacture proof for a favored hypothesis, or create a signal out of noise. Scientists must rely on and build on one another’s work. Cheating is a transgression against everything that science should be. If scientific papers contain errors or — much worse — fraudulent data and fabricated imagery, other researchers are likely to waste time and grant money chasing theories based on made-up results…..

But were those duplicated images just an isolated case? With little clue about how big this would get, I began searching for suspicious figures in biomedical journals…. By day I went to my job in a lab at Stanford University, but I was soon spending every evening and most weekends looking for suspicious images. In 2016, I published an analysis of 20,621 peer-reviewed papers, discovering problematic images in no fewer than one in 25. Half of these appeared to have been manipulated deliberately — rotated, flipped, stretched or otherwise photoshopped. With a sense of unease about how much bad science might be in journals, I quit my full-time job in 2019 so that I could devote myself to finding and reporting more cases of scientific fraud.

Using my pattern-matching eyes and lots of caffeine, I have analyzed more than 100,000 papers since 2014 and found apparent image duplication in 4,800 and similar evidence of error, cheating or other ethical problems in an additional 1,700. I’ve reported 2,500 of these to their journals’ editors and — after learning the hard way that journals often do not respond to these cases — posted many of those papers along with 3,500 more to PubPeer, a website where scientific literature is discussed in public….

Unfortunately, many scientific journals and academic institutions are slow to respond to evidence of image manipulation — if they take action at all. So far, my work has resulted in 956 corrections and 923 retractions, but a majority of the papers I have reported to the journals remain unaddressed.

Manipulated images “raise questions about an entire line of research, which means potentially millions of dollars of wasted grant money and years of false hope for patients.” Part of the problem is that despite “peer review” at scientific journals, “peer review is unpaid and undervalued, and the system is based on a trusting, non-adversarial relationship. Peer review is not set up to detect fraud.”

But there’s other problems.

Most of my fellow detectives remain anonymous, operating under pseudonyms such as Smut Clyde or Cheshire. Criticizing other scientists’ work is often not well received, and concerns about negative career consequences can prevent scientists from speaking out. Image problems I have reported under my full name have resulted in hateful messages, angry videos on social media sites and two lawsuit threats….

Things could be about to get even worse. Artificial intelligence might help detect duplicated data in research, but it can also be used to generate fake data. It is easy nowadays to produce fabricated photos or videos of events that never happened, and A.I.-generated images might have already started to poison the scientific literature. As A.I. technology develops, it will become significantly harder to distinguish fake from real.

Science needs to get serious about research fraud.
Among their proposed solutions? “Journals should pay the data detectives who find fatal errors or misconduct in published papers, similar to how tech companies pay bounties to computer security experts who find bugs in software.”

And though they partnered with Pfizer to ues the same approach for their Covid vaccine, “Now the doctors are hopeful it could lead to new treatments for melanoma, bowel cancer and other tumour types.”

BioNTech has several trials in progress, including one where patients are given a personalised vaccine, to prompt their immune system to attack their disease. The mRNA technology being used works by sending an instruction or blueprint to cells to produce an antigen or protein. In Covid this antigen is part of the spike protein of the virus. In cancer it would be a marker on the surface of tumour cells. This teaches the immune system to recognise and target affected cells for destruction.

Speaking on the BBC’s Sunday with Laura Kuenssberg, Prof Tureci said: “mRNA acts as a blueprint and allows you to tell the body to produce the drug or the vaccine… and when you use mRNA as a vaccine, the mRNA is a blueprint for the ‘wanted poster’ of the enemy — in this case cancer antigens which distinguish cancer cells from normal cells.”

Harnessing the power of mRNA to produce vaccines was unproven until Covid. But the success of mRNA vaccines in the pandemic has encouraged scientists working with the technology in cancer.

The Guardian notes that the couple said cancer-targetting vaccines could be available “before 2030”, though Özlem Türeci warns that “As scientists we are always hesitant to say we will have a cure for cancer. We have a number of breakthroughs and we will continue to work on them.”

BioNTech was working on mRNA cancer vaccines before the pandemic struck but the firm pivoted to produce Covid vaccines in the face of the global emergency. The firm now has several cancer vaccines in clinical trials.

The BBC is calling it “a discovery that completely transforms our understanding of how tumours arise.”

The team at the Francis Crick Institute in London showed that rather than causing damage, air pollution was waking up old damaged cells. One of the world’s leading experts, Prof Charles Swanton, said the breakthrough marked a “new era”. And it may now be possible to develop drugs that stop cancers forming.

The findings could explain how hundreds of cancer-causing substances act on the body. The classical view of cancer starts with a healthy cell. It acquires more and more mutations in its genetic code, or DNA, until it reaches a tipping point. Then it becomes a cancer and grows uncontrollably…. The researchers have produced evidence of a different idea. The damage is already there in our cell’s DNA, picked up as we grow and age, but something needs to pull the trigger that actually makes it cancerous….

Around one in every 600,000 cells in the lungs of a 50-year-old already contains potentially cancerous mutations. These are acquired as we age but appear completely healthy until they are activated by the chemical alarm and become cancerous. Crucially, the researchers were able to stop cancers forming in mice exposed to air pollution by using a drug that blocks the alarm signal.
The results are a double breakthrough, both for understanding the impact of air pollution and the fundamentals of how we get cancer.

Decriminalize Nature San Francisco helped advance the resolution, which also implores city officials to “instruct” its state and federal lobbyists to push for psychedelics decriminalization in California and federally. The whereas section of the measure talks about emerging research that shows entheogenic substances have therapeutic potential to treat a wide range of mental health conditions such as post-traumatic stress disorder (PTSD) and substance misuse disorder. It further notes that the “state legislature has already started the conversation around the decriminalization of personal possession of small amounts of seven psychedelic substances,” in the form of a bill from Sen. Scott Wiener (D) that passed the Senate and several Assembly committees before being significantly scaled back in a final panel and ultimately pulled by the sponsor.

U.S. Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky said even with the seven-day average of COVID hospitalizations down 14% to 4,500 per day, annual shots could save thousands of lives. “Modeling projections show that an uptake of updated COVID-19 vaccine doses similar to an annual flu vaccine coverage early this fall could prevent as many as 100,000 hospitalizations and 9,000 deaths, and save billions of dollars in direct medical costs,” she said. The redesigned boosters, green-lighted by U.S. health regulators last week, aim to tackle the BA.5 and BA.4 Omicron subvariants, which account for over 88% and 11% of circulating viruses, respectively, Walensky said. The so-called bivalent vaccines also still target the original version of the virus.

Top U.S. infectious disease expert Dr. Anthony Fauci said unless a dramatically different variant emerges, annual vaccines should offer enough protection for most people, but that some vulnerable groups might need more frequent vaccinations. “We likely are moving towards a path with a vaccination cadence similar to that of the annual influenza vaccine, with annual, updated COVID-19 shots matched to the currently circulating strains for most of the population,” he said.

To create the implant, Lagali and his team dissolved pig tissue to form a purified collagen solution. That was used to engineer a hydrogel that mimics the human cornea. Surgeons then made an incision in a patient’s cornea for the hydrogel. “We insert our material into this pocket to thicken the cornea and to reshape it so that it can restore the cornea’s function,” Lagali said. Traditionally, human tissue is required for cornea transplants. But it’s in short supply, because people must volunteer to donate it after they die. So, Lagali said, his team was looking for a low-cost, widely available substitute. “Collagen from pigskin is a byproduct from the food industry,” he said. “This makes it broadly available and easier to procure.” After two years, the patients’ bodies hadn’t rejected the implants, and they didn’t have any inflammation or scarring.

But any experimental medical procedure comes with risk. In this case, Soiberman said, a foreign molecule like collagen could induce an immune reaction. The researchers prescribed patients an eight-week course of immunosuppressive eyedrops to lower the risk, which is less than the amount given to people who receive cornea transplants from human tissue. In those cases, patients take immunosuppressive medicine for more than a year, Lagali said. “There’s always a risk for rejection of the human donor tissue because it contains foreign cells,” he said. “Our implant does not contain any cells … so there’s a minimal risk of rejection.” The procedure itself was also quicker than traditional cornea transplants. The researchers said each operation took about 30 minutes, whereas transplants of human tissue can take a couple of hours. […] It’s not yet clear whether the surgery would work for patients who have other forms of corneal disease aside from keratoconus.

[…] To create it, Glowacki took aesthetic inspiration from quantum mechanics — as he puts it, “where the definition of what’s matter and what’s energy starts to become blurred.” For their paper, Glowacki and his collaborators measured the emotional response Isness-D elicited in 75 participants. They based their measurements on four metrics used in psychedelics research — the MEQ30 (a mystical experience questionnaire), the ego dissolution inventory scale, the “communitas” scale, and the “inclusion of community in self” scale. Communitas is defined as an experience of intense shared humanity that transcends social structure. Participants’ responses were then compared with those given in published, double-blind psychedelics studies. For all four metrics, Isness-D elicited responses indistinguishable from those associated with medium doses of psychedelics. On the mystical experience scale, Isness-D participants reported an experience as intense as that elicited by 20 milligrams of psilocybin or 200 micrograms of LSD, and stronger than that induced by microdoses of either substance. The findings have been published in the journal Nature Scientific Reports.

Ultimately, the trained dogs were more sensitive to positive cases. Nasal PCR tests were better able to better detect negative cases. In two false positive cases, dogs falsely identified other coronavirus respiratory illness strains that were not Covid. While there have been previous studies on the capability of dogs to detect Covid, this is believed to be the first to compare the accuracy of dogs to antigenic tests. The study has been published in the journal Plos One.